T3
Showing 1 - 25 of >10,000
Primary Palmar Hyperhydrosis Trial in Cairo (Endoscopic thoracic T3 sympathectomy, ThoracicT3 radiofrequency ablation)
Not yet recruiting
- Primary Palmar Hyperhydrosis
- Endoscopic thoracic T3 sympathectomy
- ThoracicT3 radiofrequency ablation
-
Cairo, EgyptAin shams university
Feb 17, 2023
Stellate Ganglion, Radiofrequency Ablation, Complex Regional Pain Syndromes Trial in Cairo (Radiofrequency stellate ganglion
Not yet recruiting
- Stellate Ganglion
- +3 more
- Radiofrequency stellate ganglion block using ultrasound guidance (SGB)
- +2 more
-
Cairo, EgyptNational Cancer Institute
Sep 5, 2023
Stage T3 Squamous Cell Carcinomas of the Scalp
Active, not recruiting
- Squamous Cell Carcinoma
- +2 more
-
Maastricht, NetherlandsEllen Oyen
Aug 3, 2023
Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)
Recruiting
- Heart Failure
- Thyroid hormone T3
- Control Group
-
Atlanta, Georgia
- +1 more
Nov 14, 2022
Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)
Not yet recruiting
- Rectal Cancer
- Neoadjuvant Chemoradiotherapy
- Total Neoadjuvant Therapy
- (no location specified)
Oct 24, 2023
Peripheral Artery Disease (PAD) Trial (Stent PULSARĀ® -18 T3,)
Not yet recruiting
- Peripheral Artery Disease (PAD)
- Stent PULSARĀ® -18 T3,
- (no location specified)
Dec 26, 2022
Covid19, SARS-CoV Infection, ARDS Trial in Minneapolis (Instilled T3, Placebo Therapy)
Recruiting
- Covid19
- +3 more
- Instilled T3
- Placebo Therapy
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 1, 2022
Edentulous Jaw Trial in Italy, Spain, United States (T3 short and restoration (prosthesis), T3 standard length and restoration
Active, not recruiting
- Edentulous Jaw
- T3 short and restoration (prosthesis)
- T3 standard length and restoration (prosthesis)
-
Boston, Massachusetts
- +3 more
Mar 24, 2022
An Observational Study of the T3 Pro Dental Implant System
Not yet recruiting
- Tooth Loss
- T3 Pro dental implant system
-
New Orleans, LouisianaLouisiana State University Health Sciences Center
Aug 11, 2022
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Completed
- Rectal Cancer
- total mesorectal excision
- (no location specified)
Aug 9, 2022
Partial Edentulism, Tooth Disease Trial in Worldwide (T3 with DCD tapered Prevail implant, Nanotite Certain tapered implant)
Completed
- Partial Edentulism
- Tooth Disease
- T3 with DCD tapered Prevail implant
- Nanotite Certain tapered implant
-
Antwerp, Belgium
- +3 more
Mar 24, 2022
Edentulous Jaw Trial in Providencia, Athens (T3 Certain Tapered Implant)
Active, not recruiting
- Edentulous Jaw
- T3 Certain Tapered Implant
-
Providencia, Santiago, Chile
- +1 more
Mar 24, 2022
An Observational Clinical Study of the T3 Dental Implant System
Recruiting
- Edentulous Jaw
- T3 dental implant system
-
Gainesville, Florida
- +2 more
Mar 24, 2022
Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)
Not yet recruiting
- Aphakia
- Clareon Vivity/Vivity Toric Extended Vision IOL
- Clareon/Clareon Toric Aspheric IOL
-
Torrance, California
- +6 more
May 2, 2023
Analgesia Trial in Cairo (Thermal Radiofrequency, Chemical Neurolysis)
Recruiting
- Analgesia
- Thermal Radiofrequency
- Chemical Neurolysis
-
Cairo, EgyptWalaa Y Elsabeeny
Apr 4, 2022
CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)
Not yet recruiting
- CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
- +3 more
- (no location specified)
Nov 14, 2022
Advanced Solid Tumor Trial in Switzerland, United Kingdom (Pembrolizumab+T3P-Y058-739, T3P-Y058-739 (IV), T3P-Y058-739 (IT))
Recruiting
- Advanced Solid Tumor
- Pembrolizumab+T3P-Y058-739
- +2 more
-
Lausanne, Switzerland
- +4 more
Jun 22, 2022
p53 and Response to Preoperative Radiotherapy for T2 and T3
Recruiting
- Rectal Cancer
- preoperative short course radiation
-
Vienna, AustriaMedical University of Vienna, Department of Surgery
Apr 6, 2022
Alzheimer Trial in United States (15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959)
Active, not recruiting
- Alzheimer Disease
- 15mg T3D-959
- +3 more
-
Phoenix, Arizona
- +41 more
Jan 23, 2023
Health Status of Children Born After Assisted Reproductive
Recruiting
- Children Born After Assisted Reproductive Technologies
- +2 more
- hemogram examination
-
Almaty, KazakhstanSevara ilmuratova
Oct 17, 2023
Clareon IOL Retrospective Data Collection
Not yet recruiting
- Aphakia
- Astigmatism
- Clareon UVA IOL
- +2 more
-
Fort Worth, TexasAlcon Research, LLC
Mar 22, 2023
Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)
Completed
- Healthy
- R1: Reference Product X
- +12 more
-
Nottingham, United KingdomQuotient Sciences
Dec 7, 2022
Bone Loss, Alveolar Trial in Ann Arbor (Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition, Zimmer T3 with DCD Ex Hex
Active, not recruiting
- Bone Loss, Alveolar
- Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition
- Zimmer T3 with DCD Ex Hex Parallel Walled implants
-
Ann Arbor, MichiganUniversity of Michigan School of Dentistry
Nov 23, 2022
Cardiomyopathy Using Cardiac MRI (AID-MRI)
Not yet recruiting
- Cardiomyopathies
-
Calgary, Alberta, Canada
- +3 more
Mar 30, 2023